Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab

Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab

IntroductionSince the development of the coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), there has been significant interest in determining the effectiveness of SARS-CoV-2 vaccines in patients under immunomodulatory or immunosuppre...

Full description

Bibliographic Details
Main Authors: Elina Groß-Albenhausen, Alicia Weier, Markus Velten, Thorsten Heider, Rittika Chunder, Stefanie Kuerten
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
antibodies
B cells
CD4+ T cells
CD8+ T cells
mRNA vaccine
multiple sclerosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1254128/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1254128/full

Similar Items